Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers - a randomized controlled study.


Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 24 01 2024
accepted: 08 03 2024
medline: 18 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: epublish

Résumé

This study extended the original Dignity Therapy (DT) intervention by including partners and family caregivers (FCs) of terminally-ill cancer patients with the overall aim of evaluating whether DT can mitigate distress in both patients nearing the end of life and their FCs. In this multicenter, randomized controlled trial (RCT), a total of 68 patients with life expectancy < 6 months and clinically-relevant stress levels (Hospital Anxiety Depression total score; HADS The coalesced group (DT and DT +) revealed a significant increase in patients' perceived quality of life (FACIT-Pal-14) following the intervention (mean difference 6.15, SD = 1.86, p < 0.01). We found a statistically significant group-by-time interaction effect: while the HADS The DT intervention has been well-received and shows the potential to increase HRQoL and prevent further mental health deterioration, illness burden and suffering in terminally-ill patients. The DT intervention holds the potential to serve as a valuable tool for facilitating end-of-life conversations among terminally-ill patients and their FCs. However, the implementation of DT within the framework of a RCT in a palliative care setting poses significant challenges. We suggest a slightly modified and less resource-intensive version of DT that is to provide the DT inventory to FCs of terminally-ill patients, empowering them to ask the questions that matter most to them over their loved one's final days. This study was registered with Clinical Trial Registry (ClinicalTrials.gov -Protocol Record NCT02646527; date of registration: 04/01/2016). The CONSORT 2010 guidelines were used for properly reporting how the randomized trial was conducted.

Sections du résumé

BACKGROUND BACKGROUND
This study extended the original Dignity Therapy (DT) intervention by including partners and family caregivers (FCs) of terminally-ill cancer patients with the overall aim of evaluating whether DT can mitigate distress in both patients nearing the end of life and their FCs.
METHODS METHODS
In this multicenter, randomized controlled trial (RCT), a total of 68 patients with life expectancy < 6 months and clinically-relevant stress levels (Hospital Anxiety Depression total score; HADS
RESULTS RESULTS
The coalesced group (DT and DT +) revealed a significant increase in patients' perceived quality of life (FACIT-Pal-14) following the intervention (mean difference 6.15, SD = 1.86, p < 0.01). We found a statistically significant group-by-time interaction effect: while the HADS
CONCLUSIONS CONCLUSIONS
The DT intervention has been well-received and shows the potential to increase HRQoL and prevent further mental health deterioration, illness burden and suffering in terminally-ill patients. The DT intervention holds the potential to serve as a valuable tool for facilitating end-of-life conversations among terminally-ill patients and their FCs. However, the implementation of DT within the framework of a RCT in a palliative care setting poses significant challenges. We suggest a slightly modified and less resource-intensive version of DT that is to provide the DT inventory to FCs of terminally-ill patients, empowering them to ask the questions that matter most to them over their loved one's final days.
TRIAL REGISTRATION BACKGROUND
This study was registered with Clinical Trial Registry (ClinicalTrials.gov -Protocol Record NCT02646527; date of registration: 04/01/2016). The CONSORT 2010 guidelines were used for properly reporting how the randomized trial was conducted.

Identifiants

pubmed: 38486192
doi: 10.1186/s12904-024-01408-4
pii: 10.1186/s12904-024-01408-4
pmc: PMC10938771
doi:

Banques de données

ClinicalTrials.gov
['NCT02646527']

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73

Subventions

Organisme : Swiss Cancer League
ID : KFS-4413-02-2018
Organisme : Swiss Cancer League
ID : KFS-4413-02-2018
Organisme : Swiss Cancer League
ID : KFS-4413-02-2018

Informations de copyright

© 2024. The Author(s).

Références

Palliat Support Care. 2015 Apr;13(2):295-303
pubmed: 24762215
Curr Opin Support Palliat Care. 2015 Dec;9(4):346-54
pubmed: 26509860
J Clin Oncol. 2002 Apr 15;20(8):2134-41
pubmed: 11956275
Int J Epidemiol. 2017 Apr 1;46(2):746-755
pubmed: 28025257
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Ann Palliat Med. 2021 Jan;10(1):838-845
pubmed: 33040551
J Palliat Med. 2013 May;16(5):509-15
pubmed: 23590181
J Clin Oncol. 2005 Aug 20;23(24):5520-5
pubmed: 16110012
BMC Palliat Care. 2021 Aug 16;20(1):129
pubmed: 34399737
Int J Nurs Stud. 2016 Sep;61:136-41
pubmed: 27351830
BMJ Support Palliat Care. 2023 Jan 26;:
pubmed: 36702519
BMC Palliat Care. 2010 Sep 22;9:21
pubmed: 20860786
J Pediatr Hematol Oncol. 2011 Oct;33 Suppl 2:S140-5
pubmed: 21952572
Lancet Oncol. 2011 Aug;12(8):753-62
pubmed: 21741309
J Palliat Med. 2015 Jan;18(1):31-7
pubmed: 25314244
Cancer. 1998 May 15;82(10):1904-8
pubmed: 9587123
J Pain Symptom Manage. 2014 Jan;47(1):181-8
pubmed: 23830532
Can Fam Physician. 2018 Sep;64(9):674-679
pubmed: 30209101
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Ann Behav Med. 2002 Winter;24(1):49-58
pubmed: 12008794
Am J Hosp Palliat Care. 2004 Mar-Apr;21(2):116-20
pubmed: 15055511
Psychooncology. 2018 Dec;27(12):2840-2846
pubmed: 30251342
J Multidiscip Healthc. 2018 Mar 15;11:175-186
pubmed: 29588596
Behav Sci (Basel). 2017 Jul 14;7(3):
pubmed: 28708107
J Clin Epidemiol. 2004 Mar;57(3):229-36
pubmed: 15066682
JAMA. 2016 Nov 22;316(20):2104-2114
pubmed: 27893131
Palliat Med. 2017 Jun;31(6):492-509
pubmed: 27566756
J Hosp Palliat Nurs. 2018 Dec;20(6):542-547
pubmed: 30379798
Br J Cancer. 2009 Mar 24;100(6):908-12
pubmed: 19240713
Psychooncology. 2008 Feb;17(2):199-204
pubmed: 17549802
Palliat Med. 2012 Jul;26(5):703-12
pubmed: 21859743
J Grad Med Educ. 2013 Dec;5(4):541-2
pubmed: 24454995
J Palliat Med. 2014 Jun;17(6):688-95
pubmed: 24735024
J Clin Oncol. 2010 Jun 20;28(18):3084-9
pubmed: 20479397
J Soc Work End Life Palliat Care. 2011;7(1):83-98
pubmed: 21391079
Rev Esc Enferm USP. 2016 Nov-Dec;50(6):1014-1024
pubmed: 28198968
Psychother Psychosom. 2002 Nov-Dec;71(6):333-41
pubmed: 12411768
Soc Sci Med. 2009 Feb;68(3):562-9
pubmed: 19059687
Int J Nurs Stud. 2022 May;129:104217
pubmed: 35339908
J Palliat Med. 2011 Jun;14(6):729-34
pubmed: 21548823
J Palliat Med. 2005;8 Suppl 1:S103-15
pubmed: 16499458
BMC Palliat Care. 2015 Mar 21;14:8
pubmed: 25844066
BMC Med Res Methodol. 2014 Nov 19;14:118
pubmed: 25407057
JAMA. 2001 Jun 27;285(24):3123-9
pubmed: 11427141
Ann Palliat Med. 2021 Apr;10(4):3836-3846
pubmed: 33832298
J Pain Symptom Manage. 2008 Dec;36(6):559-71
pubmed: 18579340
Palliat Support Care. 2023 Aug 11;:1-5
pubmed: 37565429
Eur J Cancer Care (Engl). 2020 Mar;29(2):e13204
pubmed: 31978264
Psychooncology. 2021 Aug;30(8):1220-1231
pubmed: 33893677
J Pain Symptom Manage. 2021 Feb;61(2):270-278.e11
pubmed: 32768556
Ann Oncol. 2013 Jun;24(6):1639-44
pubmed: 23446094
BMC Palliat Care. 2014 Mar 19;13(1):12
pubmed: 24646211
Omega (Westport). 2013;67(1-2):135-45
pubmed: 23977789

Auteurs

Annina Seiler (A)

Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. annina.seiler@usz.ch.

Manuel Amann (M)

Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Caroline Hertler (C)

Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Sebastian M Christ (SM)

Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Markus Schettle (M)

Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Barbara Meier Kaeppeli (BM)

Department of Gynecology, University Hospital Zurich, Zurich, Switzerland.

Judith Jung-Amstutz (J)

Department of Gynecology, University Hospital Zurich, Zurich, Switzerland.

Christel Nigg (C)

Klinik Susenberg, Zurich, Switzerland.

Bernhard C Pestalozzi (BC)

Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Patrick Imesch (P)

Department of Gynecology, University Hospital Zurich, Zurich, Switzerland.

Reinhard Dummer (R)

Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

David Blum (D)

Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital Zurich and University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Josef Jenewein (J)

Privatklinik Hohenegg, Meilen, Switzerland.
University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH